Medicare prescription drug plan coverage of pharmacotherapies for opioid and alcohol dependence in WA
Պահպանված է:
Kennedy, J., et al., Medicare prescription drug plan coverage of pharmacotherapies for opioid and alcohol dependence in WA. Drug and Alcohol Dependence, Vol. 114, no. 2-3 (2011), p. 201-206.
Ref.
179359
Տեղադրություն:
SIIS R.854 Archivo
Palabras clave:
Acceso, Alcoholismo, Buprenorfina, Coste, Datos estadísticos, Drogodependencias, Fármacos, Metadona, Naltrexona, Opiáceos, Recetas médicas, Tratamiento médico, EE.UU.
Acceso, Alcoholismo, Buprenorfina, Coste, Datos estadísticos, Drogodependencias, Fármacos, Metadona, Naltrexona, Opiáceos, Recetas médicas, Tratamiento médico, EE.UU.
Նմանատիպ նյութեր: Medicare prescription drug plan coverage of pharmacotherapies for opioid and alcohol dependence in WA
- The impact of medicare prescription drug coverage on the use of antidementia drugs
- INDICATIONS, REGLES ET TECHNIQUES DE PRESCRIPTION DE LA BUPRENORPHINE
- Reasons for opioid use among patients with dependence on prescription opioids: The role of chronic pain
- SUBSTITUTION PHARMACOTHERAPIES FOR OPIOID ADDICTION: FROM METHADONE TO LAAM AND BUPRENORPHINE
- PHARMACOTHERAPIES FOR THE TREATMENT OF OPIOID DEPENDENCE. EFFICACY, COST-EFFECTIVENESS AND IMPLEMENTATION GUIDELINES
- Impact of prescription drug monitoring programs (PDMPs) on opioid utilization among Medicare beneficiaries in 10 US States